TA-270
TA-270, a novel quinolinone derivative, is a potent inhibitor of 5-lipoxygenase that plays an important role in asthma research[1].
Product Specifications
CAS Number
[194037-25-7]
UNSPSC
12352005
Target
Lipoxygenase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/ta-270.html
Smiles
O=C(NC1=CC2=C(C=C1)C(O)=C(OCCCCCCCC)C(N2C)=O)/C=C/C3=CC(OC)=C(O)C(OC)=C3
Molecular Formula
C29H36N2O7
Molecular Weight
524.61
References & Citations
[1]Y Aoki, et al. Inhibitory effect of a novel quinolinone derivative, TA-270, on asthmatic inflammatory responses in sensitized guinea pigs. Eur J Pharmacol. 2000 Dec 15;409 (3) :325-30.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-126467/TA-270-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-126467/
Scientific Category
Reference compound1
Clinical Information
Phase 2
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6391029-01 0.1 mL
PRSS8 (Prostasin, Serine Protease 8, Prostasin Light Chain, Prostasin Heavy Chain) (MaxLight 550)
Ask
View Details MBS6391029-02 5x 0.1 mL
PRSS8 (Prostasin, Serine Protease 8, Prostasin Light Chain, Prostasin Heavy Chain) (MaxLight 550)
Ask
View Details